LONDON, April 1, 2026 /PRNewswire/ — Elliott Investment Management L.P. and Elliott Advisors (UK) Limited ("Elliott"), which advise funds that together have a significant investment in Mitsui O.S.K. Lines, Ltd. ("Mitsui O.S.K." or the "Company"), today issued the following statement:

Elliott notes the initiatives outlined in Mitsui O.S.K.’s new Medium-Term Management Plan ("MTMP") as positive steps toward improving shareholder returns and increasing capital efficiency. However, Elliott remains concerned that the MTMP does not go far enough in closing Mitsui O.S.K.’s significant gap in shareholder returns to its peers or concretely addressing the large unrealized gains from vessels and real estate on the Company’s balance sheet. Mitsui O.S.K. must more ambitiously confront the factors behind its deep undervaluation. Elliott is committed to working constructively with the Company on the steps needed to achieve its stated goal of trading at a premium to book value.

About Elliott

Elliott Investment Management L.P. (together with its affiliates, "Elliott") manages approximately $79.8 billion of assets as of December 31, 2025. Founded in 1977, it is one of the oldest funds under continuous management. The Elliott funds’ investors include pension plans, sovereign wealth funds, endowments, foundations, funds-of-funds, high net worth individuals and families, and employees of the firm. Elliott Advisors (UK) Limited is an affiliate of Elliott Investment Management L.P.

Media Contacts:

London
Stijn van de Grampel
Elliott Advisors (UK) Limited
T: +44 20 3009 1061
svdgrampel@elliottadvisors.co.uk

New York
Stephen Spruiell
Elliott Investment Management L.P.
T: +1 (212) 478-2017
sspruiell@elliottmgmt.com

Tokyo
Brett Wallbutton
Ashton Consulting
T: +81 (0) 3 5425-7220
b.wallbutton@ashton.jp

Source link

This content was prepared by our news partner, Cision PR Newswire. The opinions and the content published on this page are the author’s own and do not necessarily reflect the views of Siam News Network
You May Also Like

Musim Mas and NTU Singapore Launch Multi-Year Study to Understand How Sustainability Spreads Among Smallholder Farmers

A multi-year collaboration to study what motivates smallholder farmers to adopt sustainable…

Lingnan scholar from the School of Interdisciplinary Studies co-creates breakthrough strategy for highly efficient and stable inverted perovskite solar cells – published in Nature

HONG KONG, Nov. 12, 2025 /PRNewswire/ — Perovskite solar cells (PSCs), known…

GNTbm's self-developed anti-cancer new drug GNTbm-38 has obtained IND approval from the U.S. FDA for Phase I clinical trials

TAIPEI, March 5, 2026 /PRNewswire/ — Great Novel Therapeutics Biotech & Medicals…